Serina Therapeutics, Inc.
Serina Therapeutics, Inc. (SER): 3 pipeline candidates · ~17 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
16.5 months
0% dilution
Lead: Phase 1
3 candidates
N/A
3 buys · 12 sells (180d)
A transparent, data-derived signal for Serina Therapeutics, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$29.2M
Cash
$24.5M
Quarterly Burn
$4.6M
Runway
16.5 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (3 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
21
Total value held
$1.0M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 318,272 | $617K |
| geode capital management, llc | 64,973 | $126K |
| blackrock, inc. | 58,264 | $113K |
| jane street group, llc | 39,653 | $77K |
| vanguard fiduciary trust co | 20,009 | $39K |
| state street corp | 12,758 | $25K |
| caitong international asset management co., ltd | 3,982 | $8K |
| wells fargo & company/mn | 3,606 | $7K |
| osaic holdings, inc. | 1,001 | $2K |
| tower research capital llc (trc) | 843 | $2K |
Showing top 10 of 21 institutional holders of Serina Therapeutics, Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Serina Therapeutics, Inc.'s pipeline?
Serina Therapeutics, Inc. (SER) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Serina Therapeutics, Inc.'s lead drug candidate?
Serina Therapeutics, Inc.'s most advanced tracked candidate is ser 214 (Phase 1) for Early Parkinson's and Restless Leg Syndrome.
What is Serina Therapeutics, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Serina Therapeutics, Inc. has approximately 16.5 months of cash runway.
What is Serina Therapeutics, Inc.'s market capitalization?
Serina Therapeutics, Inc.'s market capitalization is approximately $29.2M.
Who is the CEO of Serina Therapeutics, Inc.?
Mr. Steven A. Ledger is the chief executive officer of Serina Therapeutics, Inc. (SER).
Get the full picture on Serina Therapeutics, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.